Latest Pharmaceutical MACT Changes Add New Compliance Options

摘要

EPA issued revisions to the maximum achievable control technology (MACT) standards for the pharma-ceuticals production industry in an August 2, 2001 direct final rule (66 FR 40121 -40137). The pharmaceutical MACT standards, codified in 40 CFR Part 63, Sub-part GGG, regulate hazardous air pollutant (HAP) emissions from pharmaceutical facilities classified as major sources. The emission points subject to regulation under Sub-part GGG include storage vessels, process vents, wastewater streams, fugitive emissions, and heat exchange systems. The direct final rule adds compliance options for centralized combustion control devices used to limit emissions, revises the waste-water provisions, alters the storage tank requirements, and makes numerous technical corrections and revisions.